Telangiectasia, hereditary hemorrhagic, type 2
MONDO:0010880Any hereditary hemorrhagic telangiectasia in which the cause of the disease is a mutation in the ACVRL1 gene.
Also known as: ACVRL1 hereditary hemorrhagic telangiectasia, hereditary hemorrhagic telangiectasia caused by mutation in ACVRL1, telangiectasia, hereditary hemorrhagic, type 2, HHT2, ORW2, Osler Weber Rendu syndrome type 2, hereditary hemorrhagic telangiectasia type 2, pulmonary arterial hypertension, hereditary hemorrhagic telangiectasia-related
5 clinical trials for this condition and its sub-types, 0 tagged with Telangiectasia, hereditary hemorrhagic, type 2 itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
Massive new registry tracks Drug-Coated devices in real patients
Disease control Recruiting nowThis study is collecting information from 5,000 people with peripheral vascular disease who are being treated with Boston Scientific drug-eluting devices in everyday medical practice. The goal is to see how well these devices work and how safe they are in a wide range of patients…
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Tiny probes to unlock secrets of amputation healing
Knowledge-focused Recruiting nowThis study will use tiny probes called microdialysis to measure chemicals related to blood flow, inflammation, and antibiotics right inside the amputation stump after surgery. Researchers will compare results between diabetic and non-diabetic patients to understand why some stump…
Sponsor: University of Aarhus • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
Surgery black box aims to cut errors in hybrid operating rooms
Knowledge-focused Recruiting nowThis study installs a 'black box' recording system in hybrid operating rooms to capture and analyze errors during vascular procedures. Researchers will study how teamwork, leadership, and the environment affect surgical performance and patient safety. The goal is to identify high…
Sponsor: University Ghent • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC